CHM 0.00% 1.8¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-13

  1. 124 Posts.
    lightbulb Created with Sketch. 49
    Maybe it's the Hopper factor.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.